Close Menu

Jeremy Grushcow at The Cross-Border Biotech Blog breaks down how the recent amendments to Canada’s insolvency legislation pertain to intellectual property licenses. He writes that unlike in the U.S., where Section 365 (n) of the bankruptcy code protects licensees in the event that that licensor becomes insolvent, Canadian law has not offered such protection in the past.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

New analyses indicate the P.1 variant found in Brazil may be able to infect people who have already had COVID-19, the New York Times reports.

According to CNBC, Novavax's CEO says its vaccine could be authorized in the US as early as May.

The US National Institutes of Health has a new initiative to address structural racism in biomedical research.

In PNAS this week: GWAS of TLV-1-associated myelopathy/tropical spastic paraparesis, analysis of twins with hypertrophic cardiomyopathy, and more.